Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT. (Q48546353)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23291728%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23291728%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

0 references

0 references

author name string

Thomas S Rector

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23291728%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Michael Kuskowski

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23291728%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Aram Adourian

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23291728%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Pieter Muntendam

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23291728%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

4 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23291728%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23291728%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23291728%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23291728%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

511-518

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23291728%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS205

21 January 2018

Galectin-3 regulates myofibroblast activation and hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS205

21 January 2018

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS205

21 January 2018

The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS205

21 January 2018

Galectin-3: a novel mediator of heart failure development and progression

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS205

21 January 2018

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS205

21 January 2018

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS205

21 January 2018

Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS205

21 January 2018

Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS205

21 January 2018

Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS205

21 January 2018

Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS205

21 January 2018

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS205

21 January 2018

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS205

21 January 2018

Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS205

21 January 2018

Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS205

21 January 2018

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS205

21 January 2018

Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS205

21 January 2018

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS205

21 January 2018

Identifiers

10.1093/EURJHF/HFS205

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23291728%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23291728%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48546353&oldid=2098829878"